0.30% -0.005

Cardiol Therapeutics Inc (CRDL)

개요 뉴스 가격 이력 옵션 체인 CRDL 왜 하락? 토론 예측

Relative Volume:

Cardiol Therapeutics Inc Stock (CRDL) Company Profile

Cardiol Therapeutics Inc

Healthcare (1073)

최신 SEC 제출 서류

CRDL's Discussions on Twitter

Compare CRDL vs TAK, TEVA, HLN, ZTS, VTRS

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
CRDL Cardiol Therapeutics Inc	1.69	207.79M	0	-26.33M	-17.65M	-0.2824
TAK Takeda Pharmaceutical Co Adr	18.49	60.23B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	39.88	45.71B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	8.995	40.72B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	70.50	29.36B	9.51B	2.64B	2.14B	6.0361
VTRS Viatris Inc	17.95	20.48B	14.57B	-296.50M	1.64B	-0.259

Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-06-02	개시	H.C. Wainwright	Buy
2025-01-28	개시	Rodman & Renshaw	Buy
2024-06-26	개시	ROTH MKM	Buy
2024-04-22	개시	H.C. Wainwright	Buy

Cardiol Therapeutics Inc 주식(CRDL)의 최신 뉴스

Cardiol Therapeutics Inc (CRDL) 재무 분석

Cardiol Therapeutics Inc (CRDL)

Cardiol Therapeutics Inc Stock (CRDL) Company Profile

Compare CRDL vs TAK, TEVA, HLN, ZTS, VTRS

Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades

Cardiol Therapeutics Inc 주식(CRDL)의 최신 뉴스

Cardiol Expands MAVERIC Trial to Up to 150 Patients After Reaching Enrollment Target Early - the deep dive

Cardiol Therapeutics Inc. (CRDL.TO) Stock Price, News, Quote & History - Yahoo! Finance Canada

Cardiol Therapeutics Inc. (CRDL) Stock Price, News, Quote & History - Yahoo! Finance Canada

Cardiol Therapeutics Slides Under Pressure: Clinical-Stage Uncertainty and Shelf Prospectus Overhang Weigh on Investor Sentiment - kalkine.ca

Cardiol Therapeutics Inc (CRDL) Stock Price Target & Forecast - TradingKey

Cardiol Therapeutics Price Target Maintained With a $9.00/Share by HC Wainwright & Co. - Moomoo

Tejara Capital Holds 5.3% Stake in Cardiol Therapeutics (NASDAQ: CRDL), Owning 6.38 Million Shares - Kalkine Media

CRDL Reiterated by HC Wainwright & Co. -- Price Target Maintained at $9.00 - GuruFocus

Fund manager reports 6.4M Cardiol Therapeutics (NASDAQ: CRDL) shares - Stock Titan

HC Wainwright & Co. reiterates Buy rating on Cardiol Therapeutics, $9 price target - TradingView

Cardiol expands phase III trial enrollment to 150 patients By Investing.com - Investing.com Nigeria

Cardiol Therapeutics (CRDL) Advances MAVERIC Phase III Trial, Ma - GuruFocus

Cardiol Therapeutics Expands Phase III MAVERIC Trial After Early Enrollment Milestone - TipRanks

Cardiol expands phase III trial enrollment to 150 patients - Investing.com India

Cardiol Therapeutics Achieves Phase III Maveric Enrollment Target Ahead Of Schedule And Expands Pivotal Trial To Strengthen Assessment Of Cardiolrx's Efficacy - TradingView

Cardiol Therapeutics Achieves Phase III MAVERIC Enrollment Target Ahead of Schedule and Expands Pivotal Trial to Strengthen Assessment of CardiolRx™'s Efficacy - PR Newswire

Why Are Markets Watching Cardiol Therapeutics (TSX:CRDL) Midcap Shares? - kalkinemedia.com

Cardiol Therapeutics Inc. (TSX:CRDL): A Fresh Healthcare Stocks Catalyst Today - Kalkine Media

Cardiol Therapeutics Inc. (TSX:CRDL) Back In Focus For Growth Stocks Watchers - Kalkine Media

Cardiol Therapeutics Inc. (TSX:CRDL): Today's Cannabis Stocks Story - kalkinemedia.com

Cardiol Therapeutics (Nasdaq: CRDL) opens path to raise cash for heart drug trials - Stock Titan

Cardiol Therapeutics (CRDL) Raises $7M via Warrants, Extends Run - GuruFocus

Cardiol Therapeutics Announces Warrant Exercise for Over USD $7 Million in Proceeds - PR Newswire

Cardiol Therapeutics Inc. Class A (TSX:CRDL) Declines 6.86% as Selling Pressure Builds - kalkine.ca

New conduct code at Cardiol Therapeutics (CRDL) tightens conflict, confidentiality and whistleblower rules - Stock Titan

WHY TerrAscend (TSX:TSND), Cardiol Therapeutics Inc. (TSX:CRDL), Vizsla Royalties (TSXV:VROY), Quarterhill (TSX:QTRH) and GoldMining (TSX:GOLD) Could Put the TSX SmallCap Watchlist in Focus in September 2026 - kalkine.ca

CRDL: Phase III data readout and expansion into heart failure set the stage for broad market impact - TradingView

Cardiol Therapeutics: Q1 2027 Readout Will Be Make-Or-Break For MAVERIC (NASDAQ:CRDL) - Seeking Alpha

CRDL: Cardiol Therapeutics IncOrdinary SharesClass A Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

Cardiol Therapeutics (TSX:CRDL) Slides 12.34% as Volatility Returns and Investors Reassess the Clinical-Stage Risk - kalkine.ca

Cardiol Therapeutics Stock Faces Renewed Pressure as Biotech Risk and Clinical Uncertainty Weigh on Sentiment - kalkine.ca

Cardiol Therapeutics (CRDL) sets terms with new manufacturing and drug ingredient partners - Stock Titan

Cardiol Therapeutics files $150 million shelf prospectus By Investing.com - Investing.com Nigeria

Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus - TradingView

Cardiol Therapeutics files $150 million shelf prospectus - investing.com

New 25‑month shelf lets Cardiol Therapeutics (CRDL) line up future financing - Stock Titan

Cardiol Therapeutics files US$150M base shelf prospectus - tradingview.com

Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus Including Additional Disclosure Following Review by Staff of the Ontario Securities Commission - PR Newswire

Cardiol Therapeutics Inc. (NASDAQ: CRDL) to Host Fireside Chat on September 14 at H.C. Wainwright Investment Conference - Kalkine Media

Cardiol Therapeutics (NASDAQ: CRDL) lines up new shelf to fund drug trials - Stock Titan

Cardiol Therapeutics Files For Mixed Shelf Offering Of Up To $150 Mln - tradingview.com

Cardiol Therapeutics Inc. Class A (TSX:CRDL) Gains Momentum as Cardiovascular Drug Pipeline Progress Strengthens Investor Optimism - kalkine.ca

Cardiol Therapeutics (TSX:CRDL) Healthcare Stock Latest Update - Kalkine Media

Stocks in play: Cardiol Therapeutics Inc. - The Globe and Mail

Heart-drug developer Cardiol Therapeutics (CRDL) heads to a major New York investor conference - Stock Titan

Cardiol Therapeutics will join a heart-disease drug chat in New York Sept. 14 - Stock Titan

Cardiol Therapeutics to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference - PR Newswire

Cardiol Therapeutics to present at H.C. Wainwri... - Pluang

Cardiol Therapeutics Inc Class A (CRDL) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research

Cardiol Therapeutics Inc. (TSX:CRDL) Climbs 10.18% as Phase III Catalyst and CardiolRx Momentum Strengthen Investor Optimism - kalkine.ca

Cardiol Therapeutics Inc Class A (CRDL) Peer Comparison – Compare with Others - Value Research

Cardiol Therapeutics Inc (CRDL) 재무 분석

매출

순이익

현금흐름

주당 순 이익

CRDL과 유사한 종목